Medical insurance access and clinical use policy of biosimilars in European Union and its enlightenment to China

DONG Xin-yue, JIANG Rong, SHAO Rong

Chinese Journal of Hospital Pharmacy ›› 2019, Vol. 39 ›› Issue (19) : 1915-1919.

PDF(1007 KB)
PDF(1007 KB)
Chinese Journal of Hospital Pharmacy ›› 2019, Vol. 39 ›› Issue (19) : 1915-1919. DOI: 10.13286/j.cnki.chinhosppharmacyj.2019.19.01
CONTENTS IN BRIEF

Medical insurance access and clinical use policy of biosimilars in European Union and its enlightenment to China

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 39(19): 1915-1919 https://doi.org/10.13286/j.cnki.chinhosppharmacyj.2019.19.01

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1007 KB)

Accesses

Citation

Detail
Sections
Recommended
Information
Governed by: China Association for Science and Technology
Sponsored by: Chinese Pharmaceutical Association
Published by: Editorial Office of Chinese Journal of Hospital Pharmacy
ISSN 1001-5213
CN 42-1204/R
Contact
Website Copyright © Chinese Journal of Hospital Pharmacy, All Rights Reserved.
Tel: 027-82836596
E-mail：pharmacy@vip.163.com
Wechat

/

〈 〉